FibroGen (FGEN) Earnings Date, Estimates & Call Transcripts $0.40 +0.01 (+2.56%) (As of 09/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateNov. 4EstimatedActual EPS (Aug. 6) -$0.16 Beat By $0.09 Consensus EPS (Aug. 6) -$0.25 Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide Deck Get FibroGen Earnings AlertsEnter your email address below to receive the latest news and earnings results for FGEN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueFGEN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FGEN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> FibroGen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.31)($0.31)($0.31)Q2 20241($0.24)($0.24)($0.24)Q3 20241($0.23)($0.23)($0.23)Q4 20241($0.11)($0.11)($0.11)FY 20244($0.89)($0.89)($0.89)Q1 20251$0.05$0.05$0.05Q2 20251$0.06$0.06$0.06Q3 20251$0.07$0.07$0.07Q4 20251$0.06$0.06$0.06FY 20254$0.24$0.24$0.24FGEN Earnings Date and InformationFibroGen last posted its earnings data on August 6th, 2024. The biopharmaceutical company reported ($0.16) EPS for the quarter, topping analysts' consensus estimates of ($0.25) by $0.09. The firm earned $50.64 million during the quarter, compared to analyst estimates of $33 million. FibroGen has generated ($2.45) earnings per share over the last year (($2.45) diluted earnings per share). Earnings for FibroGen are expected to grow in the coming year, from ($0.91) to ($0.73) per share. FibroGen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off prior year's report dates.Read More FibroGen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/4/2024(Estimated)------- 8/6/2024Q2 2024($0.25)($0.16)+$0.09($0.16)$33.00 million$50.64 million 5/6/2024Q1 2024($0.31)($0.33)($0.02)($0.33)$41.00 million$55.90 million 2/26/2024Q4 2023($0.42)($0.57)($0.15)($0.57)$40.00 million$27.14 million 11/6/2023Q3 2023($0.68)($0.52)+$0.16($0.39)$37.10 million$40.13 million 8/7/2023Q2 2023($0.72)($0.65)+$0.07($0.40)$34.17 million$44.32 million 5/8/2023Q1 2023($0.76)($0.81)($0.05)($0.81)$31.52 million$36.16 million Get the Latest News and Ratings for FGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for FibroGen and its competitors with MarketBeat's FREE daily newsletter. 2/27/2023Q4 2022($0.95)($0.70)+$0.25($0.70)$23.95 million$34.40 million 11/7/2022Q3 2022($0.83)($0.98)($0.15)($0.98)$34.02 million$15.74 million 8/8/2022Q2 2022($0.94)($0.78)+$0.16($0.78)$36.15 million$29.81 million 5/9/2022Q1 2022($0.84)($0.68)+$0.16($0.68)$28.76 million$60.80 million 2/28/2022Q4 2021($0.68)($1.45)($0.77)($1.45)$47.65 million$16.54 million 11/9/2021Q3 2021$0.09$0.54+$0.45$0.54$135.33 million$155.97 million 8/9/2021Q2 2021($0.48)($1.45)($0.97)($1.45)$69.07 million$24.36 million 5/10/2021Q1 2021($0.90)($0.78)+$0.12($0.78)$59.48 million$38.40 million 2/28/2021Q4 2020($0.29)($0.64)($0.35)($0.64)$100.82 million$65.00 million 11/5/2020Q3 2020($0.80)$0.35+$1.15$0.35$61.49 million$44.03 million 8/6/2020Q2 2020($0.64)($0.95)($0.31)($0.95)$48.29 million$42.90 million 5/7/2020Q1 2020($0.39)($0.89)($0.50)($0.89)$72.58 million$24.40 million 3/2/2020Q4 2019($0.59)($1.12)($0.53)($1.12)$40.32 million$7.97 million 11/11/2019Q3 2019($0.59)($0.57)+$0.02($0.57)$31.61 million$33.17 million FibroGen Earnings - Frequently Asked Questions When is FibroGen's earnings date? FibroGen has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 4th, 2024 based off last year's report dates. Learn more on FGEN's earnings history. Did FibroGen beat their earnings estimates last quarter? In the previous quarter, FibroGen (NASDAQ:FGEN) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.25) by $0.09. Learn more on analysts' earnings estimate vs. FGEN's actual earnings. How can I listen to FibroGen's earnings conference call? The conference call for FibroGen's latest earnings report can be listened to online. Listen to Conference Call How can I read FibroGen's conference call transcript? The conference call transcript for FibroGen's latest earnings report can be read online. Read Transcript How much revenue does FibroGen generate each year? FibroGen (NASDAQ:FGEN) has a recorded annual revenue of $147.75 million. How much profit does FibroGen generate each year? FibroGen (NASDAQ:FGEN) has a recorded net income of -$284.23 million. FGEN has generated -$2.45 earnings per share over the last four quarters. What is FibroGen's EPS forecast for next year? FibroGen's earnings are expected to grow from ($0.91) per share to ($0.73) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Galectin Therapeutics Earnings Ventyx Biosciences Earnings Telomir Pharmaceuticals Earnings BioVie Earnings ProQR Therapeutics Earnings Amylyx Pharmaceuticals Earnings 23andMe Earnings Generation Bio Earnings Lifecore Biomedical Earnings Seres Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Is Merck Stock Undervalued After Its Colossal Earnings Growth?Polestar Lives to Fight Another Day After Q2 EarningsWhy NVIDIA’s Earnings Point to a Bullish Future for Pure StorageDoes A&F's Q2 Earnings Win Point to a Strong Holiday Season?Salesforce Beats Earnings, Raises Full-Year Profit OutlookDon’t Count Out CrowdStrike Yet: Key Insights from Q2 EarningsNVIDIA: Analysts Bullish Ahead of Earnings - Is It a Buy Now? This page (NASDAQ:FGEN) was last updated on 9/10/2024 by MarketBeat.com Staff From Our PartnersFREE TRAINING TODAY ➡️ How to profit from 2024 electionEarlier this year, Millionaire Trader Nate Bear of Monument Traders Alliance went live in front of thousands o...Monument Traders Alliance | SponsoredKamala's Plan to Bankrupt America—What You Need to KnowWhat if Kamala Wins? The 3 Words That Will Change Everything The same team that predicted Biden’s downfall ...Banyan Hill Publishing | SponsoredWarning For Nvidia HoldersHow The Boeing Disasters Could Hit Nvidia Investors You may have heard about Boeing planes falling apart mi...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredKamala Harris and The Woke Progressive NightmareNew research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an “Election M...Paradigm Press | SponsoredWall St. Icon: Looming Financial Tsunami will Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event will hit the American...InvestorPlace | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FibroGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FibroGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
